STAT
JUNE 22, 2024
First Opinion is STAT’s platform for interesting, illuminating, and maybe even provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers, and others. To encourage robust, good-faith discussion about issues raised in First Opinion essays, STAT publishes selected Letters to the Editor received in response to them.
Pharmacy Times
JUNE 22, 2024
Semaglutide was found to have effects on glycemia, inflammation, and heart failure outcomes in sub analyses.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
JUNE 22, 2024
There’s a website dedicated to asking how many days it’s been since Hank Green started a new project. The counter resets often — the multi-hyphenate internet educator and science communicator rose to prominence with his 2007 YouTube project Vlogbrothers , which he founded with his brother, the novelist-turned- tuberculosis-fighter John Green.
Drug Patent Watch
JUNE 22, 2024
This chart shows the pharmaceutical companies with the most patents in Serbia. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired. For a global perspective, see the Drug companies with the greatest global patent coverage.
Speaker: Jennifer Hill
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
Pharmacy Times
JUNE 22, 2024
There are approximately 98 million individuals have prediabetes, but approximately only 15 million actually know they have prediabetes.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Pharmacy Times
JUNE 22, 2024
Managing these treatments involves many considerations, including glycemic control and nutrition, among others.
Drug Patent Watch
JUNE 22, 2024
MOVANTIK (naloxegol oxalate) Valinor Patent: 7,056,500 Expiration: Jun 29, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.
Pharmacy Times
JUNE 22, 2024
Based on these results, tirzepatide could be first medication approved for treatment of obstructive sleep apnea in patients with obesity.
Expert insights. Personalized for you.
361 
Let's personalize your content